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Abstract The labile iron pool of cells (LIP) constitutes the 
primary source of metabolic and catalytically reactive iron in the 
eytosol. We studied LIP homeostasis in K562 cells using the 
fluorescent metal-sensitive probe calcein. Following brief ex- 
posure to iron(ll) salts or to oxidative or reductive stress, LIP 
rose by up to 120% relative to the normal level of 350 nM. 
However, the rate of recovery to normal LIP level differed 
markedly with each treatment (respective tl/2s of 27, 65-88 and 
-<17 min). We show that the capacity of K562 cells to adjust LIP 
levels is highly dependent on the origin of the LIP increase and on 
the pre-existing cellular iron status. 
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1. Introduction 
Current  models of iron acquisition, sequestration and stor- 
age by mammal ian cells invoke regulated adjustments in the 
levels of membrane Tf  receptors and cytosolic ferritin. The 
cell iron form which apparently reflects the iron status of cells 
has been associated with a weakly bound, low-molecular- 
weight fraction [1 3] which is also the presumed target of  
iron chelators [4~8]. In the prevail ing models, the chelatable 
or labile iron pool (LIP) is assumed to be sensed by a cyto- 
solic iron-responsive protein (IRP) which coordinately re- 
presses ferritin mRNA translat ion and increases transferrin 
(T O receptor mRNA stability [11]. However, the implied (in- 
verse) relationship between LIP and IRP activity [12] remains 
to be experimentally established as does its involvement in 
short-term adjustments of LIP. These issues are of physio- 
logical relevance, since it is generally assumed that LIP must 
be under strict homeostat ic ontrol not only for long-term 
metabol ic purposes, but for minimizing the potentially dama- 
ging effects of LIP [9]. This assumption is based primarily on 
the correlation found between cellular resistance to oxidative 
stress and depletion of cell iron pools induced by iron chela- 
tors [4,5,9,13]. In this work we provide experimental evidence 
for the existence of rapidly acting homeostatic mechanisms for 
maintain ing LIP at stable levels. Changes in the level of the 
cytosolic iron pool were followed continuously by a non-in- 
vasive method which we developed for in situ monitor ing of 
LIP using the fluorescent metal-sensitive probe calcein, CA 
[3,14]. 
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Abbreviations: CA, calcein; CA-AM, calcein acetoxymethyl estcr; 
LIP, intracellular labile iron pool; Tf, transferrin; SIH, salicylaldehyde 
isonicotinoyl hydrazone; FAS, ferrous ammonium sulfate; FCS, fetal 
calf serum; ME, [5-mercaptoethanol; TBHP, tert-butylhydroperoxide. 
2. Materials and methods 
2.1. Materials 
CA and its acetoxymethyl ester (CA-AM) were obtained from Mo- 
lecular Probes (Eugene, OR). The divalent metal ionophore A23187, 
ferrous ammonium sulfate (FAS), ferric ammonium citrate (FAC) 
were from Sigma Chem. Co. (St. Louis, MO). All other materials 
were of highest available grade. The iron chelator salicylaldehyde 
isonicotinoyl hydrazone (SIH) (a generous gift from Dr. P. Ponka, 
Lady Davis Institute for Medical Research, Montreal, Canada) was 
prepared as 50 mM stock solution in dimethyl sulfoxide. Chromato- 
graphically pure Tf was from Kama-Da Industries (Kibbutz Kama, 
Israel). 
2.2. Cell treatments and loading with calcein 
Human erythroleukemia K562 ceils were propagated in c~-MEM 
medium containing 7% fetal calf serum supplemented with L-gluta- 
mine and antibiotics. Manipulations of the cellular iron status were 
achieved by culturing the cells for 18 h in c~-MEM medium containing 
1 mg/ml bovine serum albumin with added 50 gg/ml human Tf (iron- 
replete) or 100 laM FAC (iron-overloaded) or no addition (iron-- 
starved). A modification of the previously published [3] method of 
CA loading and LIP determination was used. Cells were loaded at 
a density of l × 107 cells/ml with 0.25 laM CA-AM for 5 min at 37°C 
in HEPES-buffered, bicarbonate-free c~-MEM medium containing 1 
mg/ml BSA, 20 mM HEPES, pH 7.3 (0t-MEM-HEP-BSA), washed of 
excess CA-AM, resuspended in c~-MEM-HEP-BSA medium to 1 × 107 
cells/ml and maintained at room temperature until used. Just prior to 
measurements, 1 ml of the CA loaded cell suspension was centrifuged 
in a microcentrifuge and the cells were resuspended in 2 ml of pre- 
warmed 150 mM NaC1, 20 mM HEPES, pH 7.3 (HBS buffer). The 
cell suspension was transferred to a stirred, thermostatted (37°C) cuv- 
ette and CA fluorescence was measured (excitation 488 nm, emission 
517 nm, slits 10 nm, Perkin-Elmer LS-5B fluorometer quipped with a 
temperature-controlled cuvette holder and magnetic stirrer). A fluor- 
escence quenching, anti-CA antibody (10 lal/cuvette) was added in all 
experiments o eliminate xtracellular fluorescence, which amounted 
to approx. 5% of the total. The concentration f free CA accumulated 
inside cells under the above loading conditions was 9 laM, determined 
as in [3]. 
2.3. Estimation of cellular chelatable iron content with ealeein and a 
membrane permeant iron chelator 
A baseline fluorescent signal was obtained for a suspension of CA- 
loaded cells and the signal was adjusted to 70 (in a scale of 0-100). 
The increase in the fluorescence produced by the addition of the 
highly permeable iron chelator, SIH, 100 ~M, was recorded. Since 
CA is insensitive to Ca 2+ and Mg 2+ up to 1 mM [14], and the in- 
tracellular concentration of CA-quenching metals other than iron 
(Cu 2+, Co 2+ and Ni 2+) is very low, we conclude that the signal re- 
presents CA-bound iron [3,14]. 
Calibrations to determine the relationship between changes in fluor- 
escence and intracellular i on concentration were carried out by add- 
ing 10 ~tM ionophore A23187 (this produced a <5"/,, change in the 
signal), followed by 0.5 gM iron(II) added as FAS, and determining 
the corresponding change in the fluorescence. This calibration relies 
on the assumption that in the presence of A23187 iron(II) is fully 
equilibrated across the cell membrane so the CA-detectable concen- 
tration of intracellular i on is 0.5 gM. 
2.4. Cell viability 
CA has also been used extensively as a vital dye [32]. Since CA is 
retained only by viable cells, and a fluorescence-quenching, anti-CA 
antibody was present in the medium during all determinations (in 
order to quench any extracellular CA), all of the fluorescent signals 
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can be assumed to originate from within viable cells. Cell viability at 
the conclusion the experimental periods was found to be >90% in all 
cases as determined by trypan blue exclusion. 
3. Results 
3.1. Estimation of steady-state l vels of LIP with CA 
The CA method for detecting iron and analyzing LIP in 
K562 cells has been described previously [3]. It is based on 
the principle that CA loaded into cells binds a significant 
port ion of the LIP, due to its high affinity constants for 
iron(II) and (III) which are similar to those of EDTA (10 ~4 
and 1024 M -1 respectively). The CA-bound iron is revealed by 
the addit ion of excess permeant chelator which scavenges the 
cytoplasmic iron, including the CA-bound fraction, and re- 
stores CA's fluorescence. The amplitude of the chelator- 
mediated rise in fluorescence is proport ional  to the amount  
of CA-bound iron, as i l lustrated in Fig. 1A. The cells used in 
this series of studies showed average LIP levels of 350 nM 
when grown in medium with 7% fetal calf serum [3]. 
3.2. Time dependence of LIP recovery following an acute iron 
load 
We assessed the cells' capacity to restore LIP to basal levels 
after an acute rise in LIP (Fig. 1). Previously we have shown 
that iron(II) added as FAS rapidly enters K562 cells and 
accumulates in the chelatable pool [3,14]. The raw data show- 
ing the initial LIP rise in response to 20 gM FAS, and its 
subsequent decline, are shown in Fig. 1A. The kinetics of the 
recovery are shown in Fig. lB. Immediately following a 10 
min exposure of cells to 10, 20 and 40 gM FAS and resuspen- 
sion in serum-containing medium, the respective LIP in- 
creased to 137 + 10%, 154 + 10% and 226 + 46% of control 
(Table 1). Thus the magnitude of the initial rise in LIP was 
commensurate with the concentrat ion of FAS applied. The 
return to control LIP levels following iron load was biphasic, 
comprising an initial (30 min) rapid recovery, succeeded by a 
relatively slower phase. The time required for LIP to decrease 
by 50% (i.e. twz of recovery from initial max imum to control 
level) was 27 min in cells treated with 10 and 20 ~tM FAS, and 
Table 1 
Half-times of LIP recovery from various iron load conditions a 
Pretreatment b Initial LIW Recovery d 
(% of control) tl/2 (min) 
FAS 10 ~tM 137 + 10 27 
20 [aM 154 _+ 10 27 
40/aM 226 + 46 55 
H202 63 [aM 117 _+ 4 63 
125 ktM 132 _+ 5 88 
250 [aM 149 + 12 69 
TBHP 100 laM 134 _+ 6 65 
ME 2.5 mM 127 + 10 -< 17 
5.0 mM 142 + 2 -< 17 
FAC O/N 178 + 5 73 
FAC O/N & FAS 200 + 10 63 
(iron-free) O/N & FAS 164 + 7 33 
(iron-free) O/N & H202 140 _+ 8 > 90 
aValues are from data in Figs. 1-3. 
bAll treatments were for 10 min at 37°C unless indicated as O/N 
(18 h). 
CMeasured immediately following the treatment and given as % of 
untreated, iron-replete control (+ S.E.M., n = 3). 
dEstimated time required for LIP to return half-way toward un- 
treated iron-replete control levels (from Figs. 1-3). 
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Fig. 1. Recovery of LIP following an acute iron load. A: K562 cells 
(iron-replete) were incubated in the absence (control) or presence of 
20 [aM FAS for l0 min at 37°C, centrifuged and resuspended in ser- 
um-free medium, and further incubated at 37°C. At the times indi- 
cated a sample of cells was removed, loaded with CA, and assayed 
for LIP as shown. The addition of 100 /aM SIH is indicated by ar- 
rows. B: Cells were treated at FAS concentrations of 10 (I), 20 (zx), 
and 40 [aM (I) and LIP was monitored as in A. Results shown are 
relative to untreated control. 
55 min in cells treated with 40 ~tM FAS. However, only cells 
treated with 10 ktM FAS fully recovered to control values 
within the 90 rain time scale of this experiment. 
3.3. Recovery of LIP following a transient oxidative and 
reductive load in iron-replete and iron-starved cells 
Oxidative as well as reductive stress caused a dose-depend- 
ent increase in LIP. Immediately after treating iron-replete 
cells (cultured for 18 h with 50 p.g/ml human Tf) for 10 min 
at 37°C with 125 and 250 ~tM H202, and 100 ~tM tert-butyl- 
hydroperoxide (TBHP), LIP rose to 132 _+ 5%, 149 + 12 and 
134 + 6% of control respectively (Fig. 2A). This was followed 
by a gradual return to control values, with respective tl/2s of 
recovery of 88, 69 and 65 min. Exposure to 2.5 and 5 mM 
mercaptoethanol  (ME) also caused LIP to rise to 127 + 10% 
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Fig. 2. Recovery of LIP following an acute oxidative and reductive 
treatment. A: Iron-replete K562 cells were exposed to 0.125 mM 
H202 (A), 0.25 mM H202 (©), 0.1 mM TBHP (ll), 2.5 mM ME 
(A) and 5.0 mM ME (e), for 10 min at 37°C. The cells were centri- 
fuged and resuspended in serum-free medium and incubated at 
37°C. At the times indicated a sample of cells was removed, loaded 
with CA, and LIP was assayed. B: Iron-starved cells (v)  were 
treated with 0.125 mM H202 (zx) and 2.5 mM ME (A), as above 
and similarly assayed. All results shown are relative to untreated, 
iron-replete control. 
and 142 + 2% of control (Fig. 2). However, following ME 
treatment, LIP rapidly (<30 min) returned to control levels. 
Iron-starved cells, which had been cultured for 18 h in the 
absence of added iron sources, had a reduced initial LIP, 
amounting to 65 -+ 4% of iron-replete control (Fig. 2B). Fol- 
lowing exposure to 125 gM H202 and 2.5 mM ME their 
respective LIPs rose initially to 140 -+ 7 and 96 -+ 2% of the 
untreated iron-replete control. However, no significant recov- 
ery toward normal LIP levels was observed in these cells. 
3.4. Recovery o f  L IP  fol lowing an acute iron load in 
iron-replete, starved and overloaded cells 
We assessed the influence of cellular iron status on the rate 
of LIP recovery from an acute iron load (Fig. 3). The initial 
LIP was elevated to 178 + 5% in iron-overloaded cells and 
reduced to 74 + 3% in iron-starved cells, relative to iron-re- 
plete ones. After a 10 min (acute) exposure to 20 pM FAS, the 
respective LIPs of iron-overloaded, starved and replete cells 
increased to 200 + 10%, 164 + 7% and 168_+15% (all com- 
pared to untreated iron-replete control). The rates of recovery 
to iron-replete, untreated control values were essentially the 
same in iron-starved and replete cells, h/2s of both were 33 
rain. However, in iron-overloaded cells the kinetics of recov- 
ery from an acute iron load were superimposed on the kinetics 
of recovery from the long-term, 18 h iron overload. Yet, the 
tu2s of LIP recovery were roughly similar in both cases - 63 
and 73 min respectively. Thus, K562 cells retain the capacity, 
albeit restricted, to readjust LIP after a chronic iron load. 
The altered iron status of the cells cultured under different 
iron supply conditions was reflected in their relative ferritin 
content, as estimated by immunoblotting (Fig. 4). Iron- 
starved cells had ferritin levels below the level of detection, 
whereas iron-overloaded cells contained 5-fold more ferritin 
than iron-replete cells. 
4. Discussion 
The 'labile iron pool' (LIP) is an operational definition for 
cytosolic iron which is in ionic form, probably iron(II), is 
accessible to chelators, and is therefore presumed to be weakly 
bound. LIP is the iron form which is surmised to be sensed by 
IRPs. However, the dynamics of LIP-sensing mechanisms and 
their actual operation as modulators of iron sequestration 
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Fig. 3. Recovery of LIP in iron-loaded and iron-starved cells. K562 
cells were cultured for 18 h in serum-free culture medium containing 
1 mg/ml BSA with the following additions: human transferrin 50 
pg/ml (iron-replete); 100 tiM ferric ammonium citrate, FAC (iron- 
overloaded); no addition (iron-starved). The cells were centrifuged 
and resuspended in c~-MEM-Hepes medium and divided into two 
portions, one of which was exposed to 20 pM FAS for 10 min at 
37°C. The cells were then centrifuged and resuspended in serum-free 
culture medium and incubated at 37°C. At the times indicated sam- 
ples of cells were removed, loaded with CA, and LIP was assayed. 
Iron-starved, untreated: 0; iron-starved, FAS treated: II; iron-re- 
plete, untreated (control): zx; iron-replete, FAS treated: a ;  iron- 
overloaded, untreated: ©; iron-overloaded, FAS treated: e. Results 
shown are relative to iron-replete, untreated control. 
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Fig. 4. Ferritin levels in iron-replete, overloaded and starved cells. 
Cells were cultured for 18 h with either 50 lag Tf/ml (+Tff), or 100 
laM FAC (FAC), or no iron source (-TO. They were then centri- 
fuged and solubilized with 0.25% Triton X-100. 40 gg of cell extract 
protein from each sample was separated by SDS-PAGE on 10-15%0 
acrylamide gels. After electrotransfer, the blot was probed with a 
rabbit polyclonal antibody against human spleen ferritin, followed 
by horseradish peroxidase-conjugated sheep anti-rabbit IgG, and de- 
veloped in enhanced chemiluminescence (ECL) reagent. Purified hu- 
man ferritin was run as a standard (Std.). 
systems in living mammalian cells have yet to be directly 
elucidated [2,11]. A major impediment has been the difficulty 
in temporally and spatially tracing the putative form of iron 
which is 'sensed' by cells, i.e. the LIP. 
In this work we adopted a direct approach for determining 
cellular LIP, followed its dynamics and assessed the cellular 
capacity for maintaining steady levels of LIP. We used K562 
cells because of the large amount of information available on 
iron metabolism in these cells [15,16]. We focused primarily 
on how variable iron supply conditions affect LIP, and as- 
sessed the cells' capacity to restore LIP to homeostatic levels 
following evoked changes in LIP. The studies are based on 
our previous demonstration that the fluorescent, iron-sensitive 
probe CA, in conjunction with membrane permeant chelators, 
can provide a valid measure of LIP [3]. 
4.1. Chronic iron overload 
In K562 cells logarithmically growing in medium with 7% 
fetal calf serum, the steady state LIP estimated by this tech- 
nique was 350 + 100 nM, of which >80% was in the form of 
iron(II) [3]. After an 18 h incubation, LIP rose about 2-fold 
when the medium was supplemented with ionic iron(III), giv- 
en as 100 ~tM FAC (Fig. 3). Changes in cell iron load are 
known to be accompanied by concomitant changes in ferritin 
levels in these and other cells (Fig. 4, also ref. [16]). Consistent 
with the function of ferritin as a major iron-sequestering moi- 
ety, chronic iron loads of --<25 ~tM FAC produced little or no 
detectable rise in LIP (data not shown). However, 100-200 
laM FAC caused an apparently uncontrollable expansion in 
the chelatable iron pool, which failed to be matched by the 
sequestration capacity of ferritin. This is consistent with the 
observations that ingress of iron salts into cells via non-Tf 
mediated uptake pathways, is not down-regulated by iron 
overload [17,18], and is even enhanced in some cell types [19]. 
4.2. Acute iron load 
The rapid sequestration of iron from the chelatable pool is 
of particular importance in situations where cells are exposed 
to a sudden iron load. It is well established that oxidative 
damage caused by tissue ischemia/reperfusion can be signifi- 
cantly reduced by iron chelators. The basis of this preventive 
effect is believed to be the chelation of iron released from 
storage compartments, which in combination with the sudden 
oxidative burst following reperfusion, causes a rapid accumu- 
lation of oxidative radicals (reviewed in [21,22]). Iron-related 
(chelator-inhibitable) oxidative injury has also been observed 
in a variety of pathological situations: endothelial cells ex- 
posed to sources of heme [23], hearts undergoing hypothermia 
[24] or ischemia/reperfusion [25,26], erythrophagocytosing 
Kupffer cells [27], the CNS after mechanical trauma [28] 
and liver cells exposed to agents such as ethanol [29] and 
diquat [30]. Thus, an endogenous mechanism for rapid re- 
sequestration of excess cytoplasmic iron would minimize oxi- 
dative damage, similarly to the effect of externally added che- 
lators. The efficiency of this mechanism could be an important 
determinant of the capacity of cells to recover from or resist 
potential damage from transient iron loads. 
We simulated the above pathological conditions in the 
K562 cell model system. Restoration of LIP to resting levels, 
was markedly longer after an acute iron load of 40 ]aM FAS 
as compared to 10 or 20 ~tM FAS (Fig. I). This would be 
expected if at high concentrations the iron load saturated and 
exceeded the limited absorption capacity of the cells. A short 
exposure of cells to oxidative (H202) or to a reductive (ME) 
stress also produced a dose-dependent rise in LIP (Fig. 2). In 
both cases this phenomenon might be attributed to reductive 
iron release from ferritin, as has been shown in vitro for 
superoxide radicals [31] and sulfhydryl reagents [20]. The re- 
storation of the released iron to basal levels was notably 
slower in H202-treated and faster in ME-treated cells than 
in controls. Possibly, the iron sequestration mechanism, which 
might involve sulfhydryl groups, is inhibited by oxidative 
stress due to H202 and stimulated by the reducing agent 
ME. Alternatively, the two agents may release iron from dif- 
ferent sources (not necessarily ferritin), with different affinities 
for iron, resulting in different rates of re-sequestration. We 
favor the latter alternative as it is consistent with the results 
obtained with iron-starved cells (Fig. 2B). In these cells the 
amount of iron released by 0.125 mM H202 was considerably 
greater than by 2.5 mM ME, while in iron-replete cells the 
amount released by both reagents was similar (Fig. 2A). Since 
iron-starved cells have severely depleted ferritin stores (Fig. 4), 
it is conceivable that H202 released iron from non-ferritin 
sources, while ME released iron from ferritin. 
4.3. Cellular iron status and L IP  homeostasis 
We examined the influence of the cellular iron status on the 
rate of iron sequestration following an acute iron(II) load 
(Fig. 3). Cells which had been partially iron-depleted by 18 
h culture in serum-free medium showed an accordingly de- 
pressed LIP level. Since their LIP returned to control levels 
at the same rate as iron-replete cells, it would appear that the 
sequestration system is not markedly affected by previous iron 
starvation. On the other hand, recovery of LIP is 2-fold 
slower after a long-term iron overload (18 h FAC) than after 
a brief (10 min FAS) iron load. If long-term iron overload is 
associated with oxidative stress, this observation would 
further support the idea that iron sequestration capacity 
may be influenced by the oxido-reductive state of the cells. 
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The present model cell system for studying LIP and cell 
iron sequestration mechanisms enables us to address various 
questions related to possible relationships between the rate 
of iron sequestration and cellular (i) ferritin levels and iron 
status, (ii) IRP activity, (iii) oxido-reductive status and (iv) 
injury by xenobiotics or hypoxia/reoxygenation. Application 
of  these techniques to other cell types will hopefully permit 
comparative studies of the modes of handling of labile iron in 
cells from different issues and genetic origins. 
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